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Abstract
Topical antigen application is a focus of current vaccine research. This immunization route mimics natural antigen exposure
across a barrier tissue and generates T cells imprinted for skin-selective homing. Soluble antigens introduced through this
route require cross-presentation by DC to generate CD8 T cell responses. Here we have explored the relative contribution of
various skin-derived DC subsets to cross-priming and skin-selective imprinting. In our model, DC acquire soluble Ag in vivo
from immunized murine skin for cross-presentation to naı ¨ve CD8 T cells ex vivo. We find CD11b
+ migratory DC to be the
relevant cross-priming DC in this model. Both Langerin
+ and Langerin
- CD11b
+ migratory DC can cross-present antigen in
our system, but only the Langerin
+ subset can induce expression of the skin-selective addressin E-selectin ligand. Thus, the
CD11b
+ Langerin
+ migratory DC population, comprised primarily of Langerhans cells, both cross-primes naı ¨ve CD8 T cells
and imprints them with skin-homing capabilities.
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Introduction
Dendritic cells (DC) are the primary antigen (Ag)-presenting
cells that initiate T cell responses. DC were first recognized for
presenting exogenous peptides to CD4 T cells via MHCII, and
endogenous peptides to CD8 T cells via MHCI (reviewed in [1]).
Cross-presentation, a more recently recognized DC function, is the
presentation of exogenous peptides to CD8 T cells via MHCI
(reviewed in [2]). Cross-presentation is required to initiate
responses against tumor cells and intracellular pathogens that do
not directly infect DC.
DC subsets can be distinguished by surface markers and by their
positioning within tissues. DC within the skin-draining lymph
nodes (sdLN) include plasmacytoid DC, LN-resident (classical) DC
and migratory DC, which migrate from skin to sdLN. Classical
DC are MHCII
intCD11c
hi and contain CD8a
+CD11b
- and
CD8a
-CD11b
+ subsets [3]. Migratory DC can transport Ag from
skin to sdLN via afferent lymphatics [4,5], are MHCII
hiCD11c
int,
and require functional CCR7 expression to enter sdLN. This
population contains CD11b
-CD103
+ and CD11b
+CD103
- subsets.
Langerin (CD207) is expressed by all epidermal migratory DC (i.e.
Langerhans cells, LC) and some dermal migratory DC [6,7].
Despite common Langerin expression, LC and Lang
+ dermal DC
are functionally and developmentally distinct subsets [8].
CD8a
+ classical DC are considered the primary subset for cross-
priming naı ¨ve CD8 T cells [2,9] and may possess specialized
intracellular machinery for processing and presenting exogenous
Ag on MHCI [10]. Recent studies suggest that CD103
+ migratory
DC also cross-present Ag [11]. However, some of these studies
used viruses that may directly infect some DC [12], so these
findings may be attributable to classical MHCI presentation of
endogenous Ag.
DC can imprint naı ¨ve T cells to express homing molecules that
direct the primed T cells to preferentially enter certain barrier
tissues, as reviewed in [13,14]. For example, T cells in peripheral
blood use the carbohydrate ligand of E-selectin (E-lig, or CLA in
humans) to enter skin and integrin a4b7 to enter intestinal tissues
[13]. Prior work showed that peptide-pulsed DC from sdLN or
Peyer’s patches can imprint CD8 T cells to express E-lig or a4b7,
respectively [15].
We set out to more clearly define the in vivo DC subsets that
cross-present cutaneous soluble Ag and/or imprint naı ¨ve CD8 T
cells with skin-homing profiles. We used a murine in vivo system in
which DC acquire Ag from inflamed skin. We isolated these ‘‘Ag-
charged’’ DC from the sdLN of immunized mice and tested their
ability to cross-prime Ag-specific naı ¨ve CD8 T cells ex vivo. This
allowed us to test the contribution of various DC subsets to cross-
priming and tissue-selective imprinting.
Materials and Methods
Mice
C57Bl/6 CD45.2 mice were purchased from Charles River
Labs (Wilmington, MA). Lang-DTREGFP (Lang-DTR) and
PLOS ONE | www.plosone.org 1 March 2014 | Volume 9 | Issue 3 | e91054Lang-EGFP mice were a generous gift from Bernard Malissen,
Centre d’immunologie de Marseille Luminy [16]. CCR7
-/- [17]
and CD45.1 OT-I [18] mice were from our colony, the founders
obtained from Jackson Labs. (TCRa
-/- OT-I T cells were used for
some experiments, but no differences in proliferation were seen
with respect to TCRa
+ OT-I T cells.)
Topical Skin Immunization
Topical immunization of ear skin was performed as described in
[19,20]. Briefly, the stratum corneum on each side of each ear was
gently stripped with ten applications of adhesive tape (Scotch
matte finish magic tape, 3 M), taking care not to break the skin or
cause bleeding. To remove cutaneous lipids that would repel Ag in
aqueous solution, 25 ml of acetone was spread over each ear. After
evaporation of the acetone, 25 ml of an aqueous mixture
containing 1 mg/ml cholera toxin (CT) adjuvant (List Biological
Labs, Campbell, CA) was applied to each ear and uniformly
spread with a small paint brush. Control mice received only the
CT adjuvant, while experimental mice also received 50 mlo fa n
aqueous mixture containing 100 mg/ml ovalbumin (OVA) Ag
(Sigma-Aldrich product #A5503) on each ear.
Treatment of Lang-DTR mice with Diphtheria Toxin
For some cocultures (as indicated), WT or Lang-DTR mice
were treated with diphtheria toxin (DT) (List Biological Labs,
Campbell, CA). Mice were injected intraperitoneally with 1 mg
DT in 100 ml PBS. Mice were treated one day preceding
immunization and one day after immunization.
Dendritic Cell Isolation
SdLN were harvested from immunized mice, then disrupted
between frosted microscope slides and filtered through 80 mm
mesh. Remaining solid stroma was incubated for 30 min at 37 C
with 1 mg/ml collagenase (Sigma). Digested product was filtered
through mesh and added to the rest of the LN prep prior to
washing and counting.
Dendritic Cell Sorting
DC were enriched from the sdLN prep after exclusion of T and
B cells with anti-B220 (clone RA3.3A1/6.1, ATCC hybridoma
supt) and mThy-1.2 Ab (BioXCell, West Lebanon, NH) followed
by incubation with marI g k microbeads (Miltenyi Biotec, Auburn,
CA) and sorting on an AutoMACS Separator. CD8a
+ DC
selection was done using the CD8
+ dendritic cell isolation kit,
mouse (Miltenyi). Isolation of individual DC subsets was
performed on a BD FACSARIA (Becton Dickinson, San Jose,
CA).
T Cell Preparation
Spleens were harvested from CD45.1 OT-I (or OT-I TCRa
-/-)
mice for single cell suspensions. RBC were lysed and remaining
cells washed and loaded with CFSE. CD8
+ T cell selection was
performed using ‘‘CD8
+ T cell isolation kit II, mouse’’ (Miltenyi).
Coculture
After sorting, isolated populations were resuspended in 5 ml
RPMI+10% FBS and a sample taken to identify DC or CD8 T
cells by FACS analysis. A known number of 5 mm beads was
added for accurate counting. DC and T cells were plated for co-
culture in 96-well round-bottom plates. A 1:1 DC:T cell ratio was
found to provide the most reproducible T cell proliferation and
was maintained for all co-cultures. This high ratio was likely
required due to the relative rarity of DC carrying in vivo-acquired
Ag. Co-cultures were incubated for 6 days and cells stained for
FACS analysis.
In vivo Transfers
CD45.1 OT-I spleen and pLN were harvested and single cell
suspensions prepared. Red blood cells were lysed and remaining
cells were washed and loaded with CFSE. After counting,
approximately 1.5610
7 T cells were retro-orbitally injected into
anesthetized mice. Mice were immunized on ear skin (as described
above) and LNs were harvested and analyzed for T cell
proliferation five days later. WT and Lang-DTR mice were used
as recipients. DT-treated mice were injected with DT one day
before and one day after T cell transfer. Timeline: day -2, first
DTX treatment; day -1, OT-I cells transferred IV to recipients;
day 0, ear skin immunized and second DTX treatment given; day
5, skin-draining LN harvested.
Flow Cytometry
Directly conjugated mAbs were purchased from eBioscience (La
Jolla, CA) or BD Pharmingen (San Jose, CA). Flow cytometry was
performed on a BD FACS Canto (Becton Dickinson) and analyzed
by FlowJo software version 8.8.6 (Treestar, Inc., Stanford, CA).
Statistics
All statistics were performed using one-tailed Mann-Whitney U-
tests using Prism software version 5.0a (GraphPad, Inc., La Jolla,
CA).
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee of Harvard Medical School (Animal Welfare Assur-
ance of Compliance number: A3431-01). All immunizations were
performed under ketamine and xylazine anesthesia and all efforts
were made to minimize suffering.
Figure 1. Time course for peak day of sdLN DC harvest after
topical immunization for OT-I proliferation. DCs harvested from
sdLN various days after topical ear skin immunization and co-cultured
with CFSE-labeled naı ¨ve OT-I cells. Black bars: CT (adjuvant) only. White
bars:C T+ OVA protein. CD45.1
+ CD3
+ CD8
+ cells were gated for
assessment of CFSE loss. sdLN from 3-4 mice per condition were pooled
before DC isolation. Results are from two (1d, 6d) or three (2d, 4d)
independent experiments. Proliferation measured at d6 of ex vivo
culture. One-tailed Mann-Whitney p values shown. *p,.05; ***p,.0001;
n.s. = not significant.
doi:10.1371/journal.pone.0091054.g001
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Measuring functionality of individual DC subsets from
skin
We set out to examine CD8 T cell cross-priming after the
cutaneous introduction of soluble Ag. Our approach involves two
stages, the first in vivo and the second ex vivo (Fig S1). C57Bl/6
wildtype (WT) mice (or genetically-modified mice on the C57Bl/6
background) were immunized with OVA protein on ear skin along
with cholera toxin (CT) adjuvant. CT was chosen because its
properties as an adjuvant suggest that it is a promising candidate
for topical vaccination of human patients [21]. After immuniza-
tion, ‘‘Ag-charged’’ DC were isolated from cervical LN, which are
a primary sdLN downstream of the ear skin. At the same time,
splenic CD8 T cells were isolated from naive OT-I mice, which
express a transgenic TCR specific for the H2-K
b-restricted peptide
OVA257-264. The DC-enriched sdLN cells and OT-I T cells were
then co-cultured ex vivo.
The sole source of Ag in our experimental co-cultures is the
OVA protein that was topically applied several days earlier to the
DC donor mice. We also established control co-cultures in which
exogenous OVA was added directly to culture wells, to confirm
DC viability and functionality. Fig 1 shows that DC from sdLN
isolated four days post-immunization yielded the maximal OT-I
proliferative response.
The migratory DC subset is essential for CD8 T cell
proliferation
To determine whether Lang-expressing DC are necessary for
cross-presentation, we used Lang-DTR-EGFP (Lang-DTR) mice.
Diphtheria toxin (DT) receptor is knocked into the Langerin locus,
and treatment with DT leads to selective loss of Lang
+ DC,
including LC, within 24 hours [7]. WT or Lang-DTR mice were
treated with DT and immunized on ear skin. We found Lang-
depleted DC to be only ,50% as efficient as WT DC at
stimulating OT-I proliferation in our 1:1 DC/T cell co-cultures
(Fig 2A, left). The defect was restricted to Ag acquired in vivo,a s
both populations were able to cross-present exogenous Ag added
to the culture wells ex vivo (Fig 2A, right).
We next focused on the CD8a
+ DC subset. Interestingly, the
capability to cross-present in vivo-acquired Ag did not reside within
this population (Fig 2B, left). CD8a
+ DCs could, however, cross-
present exogenous OVA (Fig 2B, right).
We next assessed the cross-presentation ability of classical DC in
the absence of migratory DC. CCR7
-/- mice lack migratory DC in
sdLN, as CCR7 is required for DC migration from skin [17].
SdLN DC from CCR7
-/- mice were unable to cross-prime OT-I
cells (Fig 2C, left). CCR7
-/- sdLN DC could cross-present
exogenous OVA (Fig 2C, right).
These data, if considered by themselves, suggest that migratory
DC are required in the LN for direct Ag presentation to T cells or
Figure 2. Migratory DCs are essential for CD8
+ T cell proliferation after topical immunization. A: WT and Lang-DTR mice were topically
immunized with CT + OVA protein or CT alone. Mice were injected with diphtheria toxin (DT) five and three days prior to cell isolation. On day 4 post-
immunization, sdLN cells were isolated, enriched for DCs, and co-cultured with CFSE-labeled OT-I T cells. sdLN from 4–5 mice per condition were
pooled before DC isolation. N=4 experiments. B: CD8a
+ DCs were isolated from immunized WT mice using an AutoMACS kit. Unsorted DCs were
treated as in A. DCs were cultured with CFSE-labeled OT-I T cells. sdLN from 4–5 mice per condition were pooled before DC isolation. N=3
experiments. C: WT and CCR7
-/- mice were immunized and DC harvested on d4 post-immunization and cultured with CFSE-labeled OT-I cells. sdLN
from 4–5 mice per condition pooled before DC isolation. N=3 experiments. For all experiments shown, T cell proliferation was analyzed on day 6 of
ex vivo culture. Proliferated T cells per 1000 input T cells is depicted. Flow cytometry plots were gated on CD45.1
+ CD3
+ CD8
+ cells. Adj = adjuvant.
Ag = antigen. Tx = treatment. Left panels: The only Ag present in co-culture wells was that carried by DC from immunized mice. Right panels:
Exogenous OVA protein was directly added to ‘‘positive control’’ wells. One-tailed Mann-Whitney p values shown. *p,.01; ***p,.0001; n.s. = not
significant.
doi:10.1371/journal.pone.0091054.g002
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+ DC [2]. To distinguish between these
possibilities, we asked whether migratory DC from sdLN could
independently cross-present Ag acquired in vivo.
The ability to cross-prime naı ¨ve CD8 T cells with in vivo-
acquired Ag resides within the migratory DC subset
We used fluorescent cell sorting to separate the MHCII
hiCD11-
c
int migratory DCs into CD11b
+ CD103
- and CD11b
- CD103
+
subsets (Fig S2A). We also isolated MHCII
intCD11c
hi classical DC
(which contain the CD8a
+ DC population) for comparison with
migratory DC. Surprisingly, we found that CD11b
+ migratory DC
were the only subset to induce appreciable T cell proliferation in
co-culture; CD103
+ DC and classical DC stimulated negligible
proliferation (Fig 3A). All DC populations could cross-present
exogenous OVA (Fig 3B), proving them to remain viable and
functional after sorting.
This unexpected finding was not specific to the CT adjuvant, as
CD11b
+ migratory DC remained the sole cross-presenting
population when LPS was used as an alternative adjuvant
(Fig 3C). Furthermore, this finding was not specific to the time
point chosen for harvesting DC after immunization (day 4); we
performed identical experiments at day 2 and found that CD11b
+
migratory DC remained the only subset to induce appreciable T
cell proliferation in co-culture (albeit the proliferation was
somewhat less at this earlier time point) (Fig 3D).
We next used Lang-EGFP mice [16] as the DC source to allow
subdivision of the CD11b
+ migratory DC population into Lang
+
and Lang
- subsets by fluorescent sorting (Fig S2B). Both
populations stimulated significant T cell proliferation (Fig 3E).
Again, all DC populations could cross-present exogenous OVA
added to the culture wells (Fig 3F), proving them to remain viable
and functional after sorting.
CD11b
+ Langerin
+ DC are responsible for the majority of
E-lig imprinting on T cells
DC are capable of imprinting primed T cells to express tissue-
selective homing markers [13,14,22]. E-lig is required for entry
of T cells into skin from blood [13]. Early work showed that
Figure 3. Cross-priming ability resides within the CD11b
+ MHCII
hi subset. A: Sorted DCs from immunized mice co-cultured with CFSE-
labeled OT-I T cells. The only Ag present in co-culture wells was that carried by DC from immunized mice. Mice were immunized four days before
lymph node harvest. N=3 experiments. B: ‘‘Positive control’’ for 3A - exogenous OVA protein added to wells to confirm DC viability and functionality
post-sorting. N=3 experiments. C: Mice were immunized on ear skin four days before lymph node harvest as previously described, except LPS was
used as adjuvant instead of cholera toxin. DCs were sorted and cultured as in 3A. N=3 experiments. D: Sorted DCs from immunized mice co-cultured
with CFSE-labeled OT-I T cells. Mice were immunized two days before lymph node harvest, instead of 4 days. N=2 experiments. E: CD11b
+ migratory
DCs were subdivided into Lang
+ and Lang
- subsets. Sorted DCs from mice immunized four days before lymph node harvest were co-cultured with
CFSE-labeled OT-I T cells. N=4 experiments. F: ‘‘Positive control’’ for 3E. N=4 experiments. For all experiments shown, sdLN from 10 immunized mice
were pooled before DC sorting. T cell proliferation was analyzed on d6 of ex vivo culture with sdLN DC isolated on d4 after immunization (except for
3D). The number of proliferated T cells per 1000 input T cells is depicted. Flow cytometry plots were gated on CD45.1
+CD3
+CD8
+ cells. One-tailed
Mann-Whitney p values shown. *p,.05; **p,.001; ***p,.0001; n.s. = not significant.
doi:10.1371/journal.pone.0091054.g003
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CD8 T cells [15], but direct exposure of DC to peptide Ag in vitro
does not maintain key components of in vivo Ag transport and
processing.
Unsorted DC induced E-lig expression on proliferating CD8 T
cells, and sorted CD11b
+ migratory DC retained this function
(Fig 4A, B). However, after sorting the Lang
+ and Lang
- subsets,
we found that the ability to induce E-lig expression resided largely
within the Lang
+ population (Fig 4C, D). This is informative, as
previous work suggested that activated CD8 T cells express E-lig
by default unless they receive gut-specific imprinting signals
[15,23].
In vivo verification of ex vivo findings
Our in vivo/ex vivo assay suggested that CD11b
+Lang
+ DC are
the key subset mediating E-lig induction on naı ¨ve CD8 T cells
after topical immunization. This result implied that a mouse
lacking Lang
+ DC would be impaired in its ability to produce E-
lig
+ T cells after topical immunization. To test this hypothesis,
naı ¨ve OT-I cells were transferred directly into DTX-treated Lang-
DTR mice for comparison to other recipient mice bearing normal
numbers of Lang
+ DC. In the absence of Lang
+ DC, we found the
induction of E-lig expression on OT-I cells to be reduced
dramatically (Fig 5).
Discussion
There are at least three general mechanisms through which DC
can obtain cutaneous Ag from skin: 1) migratory DC transport Ag
directly to the sdLN [24]; 2) LN-resident classical DC obtain
soluble Ag within the sdLN from afferent lymph [25]; or 3) LN-
resident classical DC obtain Ag within the sdLN by transfer from
migratory DC [4]. The third mechanism is currently believed to
generate effective cross-presentation in vivo (reviewed in [2]).
It is important to understand the mechanism by which
immunization occurs through injured skin as investigated in this
study. One of the most successful immunization procedures in
history is Edward Jenner’s 18
th century inoculation of patients with
non-virulent vaccinia virus through skin scarification to protect
against smallpox. It has been proven today that the skin
scarification method of immunization is many times more effective
for this particular virus than more modern inoculation methods
such as subcutaneous injection [26]. This suggests that antigen
delivery through skin can induce a type of immune reaction
different from those induced through other routes.
We have established a model system to study cross-presentation
by loading DC with Ag through a tissue-specific immunization
route in vivo, and used these ‘‘Ag-charged’’ DC to elicit
proliferation and activation of Ag-specific naı ¨ve T cells ex vivo.
Our approach goes beyond the abilities of many existing models,
which remove any physical or mechanistic barriers that might
normally prevent a given DC subtype from accessing Ag in vivo.
Figure 4. CD11b
+Langerin
+MHCII
hi DCs induce E-lig. A: Representative example of E-lig expression on CD8 T cells after co-culture with
unsorted DCs or sorted CD11b
+ MHCII
hi DCs. Control was stained in the presence of EDTA (which disrupts Ca
++-dependent E-selectin binding) to
determine non-specific binding of the E-selectin-Ig chimera. Flow cytometry plots are gated on CFSE-low CD8
+ T cells. Vertical axis: side scatter. Plots
representative of 3 different experiments of 5–8 wells each (depending on DC yield). 3433 cells shown per panel. B: E-lig expression depicted as the
percentage of proliferated T cells expressing high levels of E-lig. E-lig
hi expression was observed only on proliferated T cells, so undivided T cells are
not included in the calculation. Data from co-cultures with unsorted DCs or sorted CD11b
+ MHCII
hi DCs are compared within a given experiment.
sdLN from 10 immunized mice were pooled before DC sorting. N=3 experiments. One-tailed Mann-Whitney p values shown. n.s. = not significant. C:
Representative example of E-lig expression on CD8 T cells after co-culture with CD11b
+ Lang
+ or CD11b
+ Lang
- MHCII
hi DCs. Control stained as in A.
Flow cytometry plots are gated on CFSE-low CD8
+ T cells. Vertical axis: side scatter. Plots are representative of samples from 4 different experiments
of 3–8 wells each (depending on DC yield). 1623 cells shown per panel. D: E-lig expression depicted as the percentage of proliferated OT-I T cells that
are E-lig
hi as in B, Data from co-cultures with unsorted DCs and sorted Lang
+ or Lang
- CD11b
+ MHCII
hi DCs compared within a given experiment. sdLN
from 10 immunized mice were pooled before DC sorting. N=4 experiments. One-tailed Mann-Whitney p values shown. *p,.01; ***p,.0001.
doi:10.1371/journal.pone.0091054.g004
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complex three-dimensional developmental niches of the intact skin
and sdLN, which would be difficult if not impossible to accurately
reproduce in vitro with current technology. Thus, our approach
combines the robustness of a reductionist ex vivo model with the
crucial in vivo components of Ag-acquisition by DC and subsequent
transport of Ag to the LN. This approach has provided us with
significant advantages towards understanding the cells, molecules
and processes required for Ag cross-presentation, and the potential
for such immunization routes to generate tissue-specific cellular
immune responses in human patients.
The question of which skin-resident DC subset is responsible for
the cross-presentation of soluble Ag is quite well studied, but far
from resolved. Our results demonstrate that CD11b
+ migratory
DC cross-present soluble protein Ag applied to skin. We found all
other DC subsets essentially incapable of cross-priming CD8 T
cells with in vivo-acquired Ag. This is surprising, given the
association of CD8a
+ classical DCs and CD103
+ migratory DCs
with cross-presentation in other contexts, especially as these DCs
are thought to be developmentally related [2,9,11]. However,
under our co-culture conditions, neither of these subsets was able
to cross-prime CD8 T cells. We found that CD11b
+ migratory DC
cross-prime CD8 T cells directly, not by licensing other DC
populations. By using an approach that requires DC to acquire Ag
in vivo, we have preserved the physical barriers that may prevent
some DC from accessing Ag in vivo. As all DC subsets tested were
capable of cross-presenting Ag added directly to culture wells, this
finding emphasizes the importance of Ag access, which can only
be observed in vivo.
Most interestingly, we also found that not all DC subsets that
can cross-prime CD8 T cells are also capable of imprinting them
for skin-selective homing (Fig 4). Our data demonstrate that the
entire population of CD11b
+ migratory DC can cross-present in
vivo-acquired Ag, but only the Lang
+ subset could effectively
imprint the activated CD8 T cells to express E-lig. This finding
was confirmed in vivo by demonstrating that adoptively transferred
OT-I populations within the skin-draining nodes of hosts lacking
Lang
+ DC contained dramatically fewer E-lig
+ cells.
Some have suggested that imprinting T cells to express homing
markers is independent of activation site or tissue of origin [27].
Other work has focused on stromal or LN microenvironment
factors [28,29]. The variation in E-lig imprinting between Lang
+
and Lang
- CD11b
+ migratory DC strongly suggests that skin-
selective imprinting requires signals distinct from those that
stimulate proliferation. It also implies that imprinting is an
instructive process orchestrated by DC, independent of contem-
poraneous exposure to afferent lymph or LN-derived stroma cells
(albeit such factors may influence DC imprinting capabilities prior
to ex vivo culture).
The immunophenotype of the population we found capable of
both cross-presentation and imprinting is consistent with that of
LC (i.e. Lang
+ CD11b
+ CD103
- DC within the MHCII
hi CD11c
int
migratory DC population). The cross-presentation capability of
LC has been controversial, with some showing LC to be
unnecessary for CD8 T cell responses [30,31], and others showing
them to be important [21,32]. Work with LC ablation models has
offered mixed results with regard to the role of LC in contact
hypersensitivity (reviewed in [33]). The finding that LC transfer
HSV Ag to CD8a
+ DC that then prime CD8 T cells supports the
idea that LC do not directly cross-prime T cells [4]. However,
other work has found LC pulsed ex vivo with Ag to be capable of
cross-presentation [34,35]. The present study demonstrates that
each DC subset we isolated from sdLN is capable of cross-
presentation when pulsed with OVA ex vivo (Figs 3B, 3F).
Importantly, however, we have demonstrated that when OVA is
applied physiologically, requiring passage of Ag through the skin
barrier tissue, only the CD11b
+ migratory DCs are able to cross-
present. While the LCs are not the only DC subset to cross-present
(the Lang
- CD11b
+ migratory DCs do so as well), they are the only
DC subset able to imprint E-lig.
The lack of consensus on LC cross-presentation ability may
stem from the use of different Ag under varying immunization
conditions. DC subsets that do not typically cross-present Ag may
do so when competing DCs are removed. Using LC depletion
models to examine the role of LC could thus obscure their true
role in vivo, especially if the depletion is chronic. However, acute
depletion models are useful for narrowing down DC subsets for
further investigation, as we have done in the current study. In
addition, it is possible that LC directly present some Ag (e.g. soluble
protein Ag), but transfer others (e.g. HSV Ag) to LN-resident DC.
Further studies are required to build a complete picture for the
role of LC in cross-presentation, but we have demonstrated the
Figure 5. Decreased proliferation and E-lig induction for OT-I
cells adoptively transferred into Lang
+ DC-depleted mice. CFSE-
labeled splenocytes from CD45.1+ OT-I donor mice were injected iv into
recipient WT and Lang-DTR mice. On the following day, recipients were
topically immunized with CT+OVA protein or CT alone on the ear skin,
using the same immunization techniques as in our in vivo/ex vivo
assays. All mice were treated with twice diphtheria toxin. Timeline: day -
2, first DTX treatment; day -1, OT-I cells transferred IV to recipients; day
0, ear skin immunized and second DTX treatment given; day 5, skin-
draining LN harvested. A: Proliferation depicted as the percentage of
total OT-I T cells that are CFSE low. B: E-lig expression depicted as the
percentage of total. N=3 experiments of 4–5 mice per group. For all
experiments shown, sdLN cells were isolated and gated on
CD45.1+CD3+CD8+ cells. One-tailed Mann-Whitney p values shown.
*p,.05; **p,.001; ***p,.0001; n.s. = not significant.
doi:10.1371/journal.pone.0091054.g005
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markers on CD8 T cells.
Interestingly, LC are often considered to be tolerogenic, as LC
internalize self-Ag in the steady state without causing autoimmune
responses [36]. LC also arrive late in the sdLN and inefficiently
induce CD80 and CD86 [24]. However, it should be noted that
peak T cell proliferation occurred in our system when DC were
harvested at day 4 after in vivo immunization (Fig 1), the peak day
for LC arrival in the sdLN [24]. It is possible that LC
tolerogenicity depends on maturation state (reviewed in [37]), as
immature LC can migrate to draining LN [38]. Also, as LC were
not distinguished from Lang
+ dermal DC in many earlier studies,
Lang
+ dermal DC may cause the tolerogenic effects currently
ascribed to LC [11,39], reviewed in [37].
We found that the ability to cross-present skin-derived
exogenous protein Ag under our experimental conditions resided
within the CD11b
+ subset of CCR7
+ migratory DC. Within this
subset, only the Lang
+ DCs efficiently induced E-lig expression.
This is a novel biological finding, supporting the notion that tissue-
selective imprinting is an instructive process. It would be
enlightening to further explore how different environmental
conditions affect the DC’s ability to cross-present; this would be
key for DC vaccine design, as targeting a vaccine to a specific DC
subset would only be useful if that subset cross-presented Ag under
the conditions used for vaccine application.
Supporting Information
Figure S1 Description of cell isolation and co-culture setup.
DCs: cells were harvested from skin-draining lymph nodes (sdLN)
post-topical skin immunization on ears and pooled within each
group. Pooled cells were depleted of T and B cells and counted. T
cells: spleen from OT-I mouse was harvested and red blood cells
were lysed. Cells were labeled with CFSE and enriched for CD8
+
T cells with an AutoMACS kit. DCs and T cells were cultured in a
1:1 ratio. After 6 days of culture, cells were harvested and stained
for flow cytometry analysis.
(TIF)
Figure S2 Depiction of dendritic cell subset sorting strategies. A:
To isolate DCs for Fig 3A, sdLN cells were first sorted on MHCII
vs CD11c expression. CD11c
hi MHCII
int (‘‘LN-resident’’) den-
dritic cells were sorted as one population. CD11c
int MHCII
hi
migratory DCs were sorted into CD11b
+ and CD103
+ sub-
populations. B: To isolate DCs for Fig 3D, sdLN were first sorted
based on MHCII vs CD11c expression. CD11c
hi MHCII
int (‘‘LN-
resident’’) dendritic cells were sorted as one population. CD11c
int
MHCII
hi migratory DCs were sorted into CD11b
+ and CD103
+
sub-populations; CD11b
+ DCs were further divided based on
Langerin-EGFP expression.
(TIF)
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